Abstract: Recruiting and retaining patients in rare disease clinical trials remains a persistent challenge, particularly when eligibility criteria are restrictive and patient populations are geographically dispersed.

Abstract: This case study highlights how Science 37 and Catalent successfully navigated the challenges of a Phase 3 rare disease neurology study for narcolepsy.

This case study highlights how Science 37 and Catalent successfully navigated the challenges of a Phase 3 rare disease neurology study for narcolepsy.

Summary: As clinical trials grow increasingly decentralised and patient-centric, traditional clinical supply chains often fall short.

As clinical trials grow increasingly decentralised and patient-centric, traditional clinical supply chains often fall short.

Decentralized clinical trials (DCTs) are reshaping the clinical research landscape by improving access, compliance, and operational efficiency

Discover how leveraging innovative solutions and proactive planning can transform the efficiency and reliability of your clinical supply chain.

As clinical trials grow more complex and global in scope, traditional supply chain strategies are being pushed to their limits

A Case Study - Global decentralized trials demand clinical supply solutions that are fast, efficient, and sustainable, especially when product availability is limited.

A Case Study - Discover how Catalent used FastChain® Demand-Led Supply to help the sponsor overcome these hurdles and ensure quick delivery and administration of this therapy to patients.